论文信息 - LBA66 IMmotion010: Efficacy and safety from the phase III study of atezolizumab (atezo) vs placebo (pbo) as adjuvant therapy in patients with renal cell carcinoma (RCC) at increased risk of recurrence after resection - 字舞流文

LBA66 IMmotion010: Efficacy and safety from the phase III study of atezolizumab (atezo) vs placebo (pbo) as adjuvant therapy in patients with renal cell carcinoma (RCC) at increased risk of recurrence after resection

R. Uzzo | J. Karam | M. Zibelman | F. Donskov | C. Suarez | G. Procopio | F. Massari | B. Rini | W. Leung | A. Kann | A. Bex | L. Albiges | M. Huseni | Y. Tomita | I. Antonyan | S. K. Pål | O. Khan | B. Ci | V. Master | D. Basu